ARCA biopharma, Inc. 4
4 · ARCA biopharma, Inc. · Filed Feb 21, 2017
Insider Transaction Report
Form 4
BRISTOW MICHAEL R
DirectorChief Science and Med. Officer
Transactions
- Award
Stock Option (right to buy)
2017-02-16+42,000→ 42,000 totalExercise: $2.50Exp: 2027-02-15→ Common Stock (42,000 underlying)
Holdings
- 42,638
Common Stock
- 25,459(indirect: By IRA)
Common Stock
- 19,986(indirect: By Trust)
Common Stock
Footnotes (2)
- [F1]Includes (i) remaining 4,050 previously reported shares issued as Restricted Stock Units ("RSUs") under the 2013 Amended and Restated Equity Incentive Plan (the "Plan") that vest in two equal annual installments beginning on 2/27/17, and (ii) 4,581 previously reported shares issued as RSUs under the Plan that vest in two equal annual installments beginning 4/2/17, provided that the Reporting Person's continuous service to the Issuer has not been terminated as defined under the Plan; and 34,007 previously reported shares of common stock held directly.
- [F2]Grant to the Reporting Person of a stock option under the Plan, vesting in 36 equal monthly installments from the date of grant, provided that the Reporting Person's continuous service to the Issuer has not been terminated as defined in or as determined under the Plan prior to such time. In the event of a change in control of the Issuer, 50% of the unvested options shall become fully and immediately vested upon the closing date of such change in control, provided, however, that on the earlier of (i) the one-year anniversary of the closing date or (ii) involuntary termination, any options that remain unvested on such earlier date shall become fully and immediately vested.